JP2012506417A - 上皮組織処置用組成物 - Google Patents

上皮組織処置用組成物 Download PDF

Info

Publication number
JP2012506417A
JP2012506417A JP2011532758A JP2011532758A JP2012506417A JP 2012506417 A JP2012506417 A JP 2012506417A JP 2011532758 A JP2011532758 A JP 2011532758A JP 2011532758 A JP2011532758 A JP 2011532758A JP 2012506417 A JP2012506417 A JP 2012506417A
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
topiramate
scar
skin
oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011532758A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012506417A5 (enExample
Inventor
ネイサン， アンドリュー シャピラ，
アミル バージレイ，
Original Assignee
ノヴォデルミックス インターナショナル リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ノヴォデルミックス インターナショナル リミテッド filed Critical ノヴォデルミックス インターナショナル リミテッド
Publication of JP2012506417A publication Critical patent/JP2012506417A/ja
Publication of JP2012506417A5 publication Critical patent/JP2012506417A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Toxicology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2011532758A 2008-10-21 2009-10-21 上皮組織処置用組成物 Pending JP2012506417A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13699408P 2008-10-21 2008-10-21
US61/136,994 2008-10-21
PCT/IB2009/054646 WO2010046861A1 (en) 2008-10-21 2009-10-21 Composition for treatment of epithelial tissue

Publications (2)

Publication Number Publication Date
JP2012506417A true JP2012506417A (ja) 2012-03-15
JP2012506417A5 JP2012506417A5 (enExample) 2012-12-13

Family

ID=42118987

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011532758A Pending JP2012506417A (ja) 2008-10-21 2009-10-21 上皮組織処置用組成物

Country Status (9)

Country Link
US (1) US20110257257A1 (enExample)
EP (1) EP2361083A4 (enExample)
JP (1) JP2012506417A (enExample)
KR (1) KR20110074611A (enExample)
CN (1) CN102256602A (enExample)
BR (1) BRPI0914454A2 (enExample)
CA (1) CA2741028A1 (enExample)
RU (1) RU2011120054A (enExample)
WO (1) WO2010046861A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024515787A (ja) * 2021-04-27 2024-04-10 シャンドン ベンジェン コスメティックス カンパニー， リミテッド 水中油型エマルションおよび乳児湿疹に耐えることにおけるその使用

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9962391B2 (en) 2011-12-27 2018-05-08 Cmpd Licensing, Llc Composition and method for compounded therapy
US11213500B2 (en) 2011-12-27 2022-01-04 Cmpd Licensing, Llc Composition and method for compounded therapy
US10813897B2 (en) 2011-12-27 2020-10-27 Cmpd Licensing, Llc Composition and method for compounded therapy
US11213501B2 (en) 2011-12-27 2022-01-04 Cmpd Licensing, Llc Composition and method for compounded therapy
US9468599B2 (en) 2011-12-27 2016-10-18 Cmpd Licensing, Llc Composition and method for compounded therapy
JP6049862B2 (ja) * 2012-09-07 2016-12-21 株式会社 資生堂 フィブリン３及び／又はサルコグリカンγを指標としたセルライトの評価方法及びセルライト効果薬剤の評価方法
CN105073860B (zh) 2013-02-26 2018-09-21 旭化成建材株式会社 酚醛树脂发泡板及其制造方法
WO2022204350A1 (en) * 2021-03-24 2022-09-29 Orgenesis Inc. Compositions comprising topiramate for treating dermatological conditions

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352442A (en) * 1985-07-18 1994-10-04 Proctor Peter H Topical tempo
JP2002542149A (ja) * 1998-12-23 2002-12-10 グラクソ グループ リミテッド ジメチコンを含むアシクロビール組成物
WO2003097038A1 (en) * 2002-05-14 2003-11-27 Ralph Ryback Method for treating dermatoses and tissue damage
JP2006505583A (ja) * 2002-10-25 2006-02-16 フォーミックス エルティーディー． 化粧剤および医薬用フォーム

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3784692A (en) * 1967-06-16 1974-01-08 Warner Lambert Co 17-propionate,21-ester derivatives of 6alpha,9alpha-difluoroprednisolone,compositions and use
US4323694A (en) * 1981-04-13 1982-04-06 Finetex, Inc. Benzoic acid esters
GB9106678D0 (en) * 1991-03-28 1991-05-15 Ferguson Mark W J Wound healing
US6284234B1 (en) * 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
IL137559A (en) * 2000-07-27 2006-12-31 Amnon Sintov A system for administering drugs through the skin
US20020082222A1 (en) * 2000-11-30 2002-06-27 Shapira Nathan Andrew Treatments for neurogenetic disorders, impulse control disorder, and wound healing
FR2829693B1 (fr) * 2001-09-20 2004-02-27 Oreal Creme cosmetique moussante
US6824786B2 (en) * 2001-11-27 2004-11-30 Ruey J. Yu Compositions comprising phenyl-glycine derivatives
US6559293B1 (en) * 2002-02-15 2003-05-06 Transform Pharmaceuticals, Inc. Topiramate sodium trihydrate
US20080031907A1 (en) * 2002-10-25 2008-02-07 Foamix Ltd. Cosmetic and pharmaceutical foam
EP1635770B1 (en) * 2003-03-21 2009-05-27 Nexmed Holdings, Inc. Antifungal nail coat and method of use
US6949518B1 (en) * 2003-06-25 2005-09-27 Pao-Hsien Chu Methods for treating macular degeneration with topiramate

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352442A (en) * 1985-07-18 1994-10-04 Proctor Peter H Topical tempo
JP2002542149A (ja) * 1998-12-23 2002-12-10 グラクソ グループ リミテッド ジメチコンを含むアシクロビール組成物
WO2003097038A1 (en) * 2002-05-14 2003-11-27 Ralph Ryback Method for treating dermatoses and tissue damage
JP2006505583A (ja) * 2002-10-25 2006-02-16 フォーミックス エルティーディー． 化粧剤および医薬用フォーム

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024515787A (ja) * 2021-04-27 2024-04-10 シャンドン ベンジェン コスメティックス カンパニー， リミテッド 水中油型エマルションおよび乳児湿疹に耐えることにおけるその使用

Also Published As

Publication number Publication date
EP2361083A4 (en) 2013-11-20
BRPI0914454A2 (pt) 2015-10-27
EP2361083A1 (en) 2011-08-31
US20110257257A1 (en) 2011-10-20
RU2011120054A (ru) 2012-11-27
CA2741028A1 (en) 2010-04-29
KR20110074611A (ko) 2011-06-30
CN102256602A (zh) 2011-11-23
WO2010046861A1 (en) 2010-04-29

Similar Documents

Publication Publication Date Title
JP2012506417A (ja) 上皮組織処置用組成物
JP6566531B2 (ja) 脂肪組織の減少
US10973848B2 (en) Compositions and methods for treating conditions of compromised skin barrier function
US20140255521A1 (en) Topical compositions and methods of treatment of topical disorders
JP5580210B2 (ja) 手術前治療
RU2703713C2 (ru) Композиции для местного нанесения, содержащие биматопрост, и способы стимуляции роста волос с их помощью
JP7421558B2 (ja) 組織修復に適用されるピルフェニドンを含有する半固体油性医薬組成物
CN103816165B (zh) 一种治疗痤疮的组合物
TW201210601A (en) Compounds and methods for skin repair
WO2005027977A2 (en) Diclofenac compositions for the treatment of skin disorders
JP2024542045A (ja) 汎ｂｅｔ阻害剤の使用
US10543172B2 (en) Econazole composition and methods of treatment therewith
Toppo et al. Development, optimization and evaluation of different herbal formulations for wound healing
JP2020520927A (ja) 表皮水疱症の治療および防止におけるコエンザイムｑ１０製剤の使用
WO2006065870A2 (en) Topical numbing composition for laser therapy
US20140315991A1 (en) Composition for treatment of epithelial tissue
KR20240134863A (ko) 심부 진피 약물 전달을 위한 스피로노락톤의 약학 조성물
KR20160117529A (ko) 헤파린의 국소 제제
Pielenhofer Quality, safety and efficacy of a novel nanoparticulate imiquimod formulation
HK40014982A (en) Reduction of adipose tissue
HK40014982B (en) Reduction of adipose tissue
EP2845591A1 (en) Use of trifluoroacetic acid as keratolytic agent to treat hyperkeratotic skin lesions

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121022

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20121022

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140114

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140411

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20141202